Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 1787Neoplasms 1504Carcinoma, Non-Small-Cell Lung 1046Prostatic Neoplasms 962Colorectal Neoplasms 881Lung Neoplasms 805Pancreatic Neoplasms 572Carcinoma, Hepatocellular 545Leukemia, Myeloid, Acute 542Stomach Neoplasms 514Ovarian Neoplasms 507Neoplasm Metastasis 501Multiple Myeloma 494Recurrence 412Melanoma 387Squamous Cell Carcinoma of Head and Neck 369Brain Neoplasms 365Uterine Cervical Neoplasms 361Head and Neck Neoplasms 358Esophageal Neoplasms 312Precursor Cell Lymphoblastic Leukemia-Lymphoma 311Lymphoma 306Endometrial Neoplasms 304Triple Negative Breast Neoplasms 301Glioblastoma 300Rectal Neoplasms 284Sarcoma 267Urinary Bladder Neoplasms 266Hematologic Neoplasms 265Colonic Neoplasms 255

Interventions

Pharmaceutical Preparations 1Irinotecan 1Fluorouracil 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × BRAF V600 Colorectal Cancer × Clear all
NCT07150247 2025-09-26

Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer

Sun Yat-sen University

Phase 2 Recruiting
20 enrolled
Gastrointestinal

BRAF V600 Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡